Collectively, these findings indicate that cynaroside attenuates hepatocyte senescence through the enhancement of HMGCS2 expression and subsequent ketogenesis, thereby ameliorating the pathological manifestations of NASH-T2DM. The gene discussed is HMGCS2; the disease is metabolic dysfunction-associated steatohepatitis.